Nadroparin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Nadroparin is a form of low molecular weight heparin.

• http://www.cancer.gov/Templates/drugdictionary.aspx?CdrID=483128
• http://www.mayoclinic.com/health/drug-information/DR600971
• Shafiq N, Malhotra S, Pandhi P, Sharma N, Bhalla A, Grover A (2006). “A randomized controlled clinical trial to evaluate the efficacy, safety, cost-effectiveness and effect on PAI-1 levels of the three low-molecular-weight heparins–enoxaparin, nadroparin and dalteparin. The ESCAPe-END study”. Pharmacology. 78 (3): 136–43. doi:10.1159/000096484. PMID 17057417.CS1 maint: Multiple names: authors list (link)